Advertisement
YOU ARE HERE: LAT HomeCollectionsVioxx Drug
IN THE NEWS

Vioxx Drug

FEATURED ARTICLES
BUSINESS
April 12, 2006 | From the Associated Press
A jury awarded $9 million in punitive damages on Tuesday to a man who blamed his heart attack on Vioxx, finding that Merck & Co. failed to warn about risks of its arthritis drug and misrepresented side effects to physicians. The damages are in addition to $4.5 million already awarded to John McDarby, 77, of Park Ridge, N.J., who suffered a heart attack after four years on Vioxx, a painkiller taken by 20 million Americans before being pulled off the market.
ARTICLES BY DATE
BUSINESS
July 26, 2007 | From Times Wire Services
The increased heart risk from Vioxx, Merck & Co.'s withdrawn arthritis medicine, begins much earlier than after 18 months of use, according to a study contradicting assertions by the drug maker and its scientists. The 2,434-patient study, published in the New England Journal of Medicine, was halted early when the medicine was pulled from the market in September 2004. Although the median duration of treatment was only 7.
Advertisement
BUSINESS
August 18, 2006 | Lisa Girion, Times Staff Writer
Merck & Co. suffered two setbacks Thursday in litigation over its withdrawn painkiller Vioxx, with a Newport Beach product-safety lawyer playing a lead role in one of those losses. In New Orleans, a federal jury ordered Merck to pay $51 million to a health-conscious retired FBI agent who suffered a heart attack at age 58 after taking the blockbuster drug for about 2 1/2 years.
BUSINESS
July 4, 2007 | From Times Wire Services
A federal judge ruled that Merck & Co. must defend lawsuits over its Vioxx painkiller, rejecting an argument that U.S. regulations preclude patients from claiming they weren't warned about the drug's risks. U.S. District Judge Eldon Fallon in New Orleans denied Merck's request to dismiss two cases on the grounds that the Vioxx warning label was approved by the Food and Drug Administration.
BUSINESS
December 15, 2004 | From Associated Press
Pharmaceutical giant Merck & Co., under siege over revenue lost since it recalled arthritis drug Vioxx, will have cut about 5,100 jobs by year-end, 700 more than first planned, and will slash costs by $2.4 billion over four years, Chairman and Chief Executive Raymond V. Gilmartin said Tuesday. Gilmartin, speaking to about 250 analysts during Merck's annual business briefing, said the company was accelerating changes to increase growth, but would stick with its strategy of shunning major mergers.
BUSINESS
July 6, 2005 | From Associated Press
A judge on Tuesday declined to postpone the first wrongful-death trial related to the painkiller Vioxx but said he would check questionnaires filled out by potential jurors for evidence that they were biased by pretrial publicity. "For now, we're going to keep going," state District Judge Ben Hardin told lawyers for Merck & Co., the manufacturer of Vioxx.
BUSINESS
July 4, 2007 | From Times Wire Services
A federal judge ruled that Merck & Co. must defend lawsuits over its Vioxx painkiller, rejecting an argument that U.S. regulations preclude patients from claiming they weren't warned about the drug's risks. U.S. District Judge Eldon Fallon in New Orleans denied Merck's request to dismiss two cases on the grounds that the Vioxx warning label was approved by the Food and Drug Administration.
BUSINESS
August 2, 2005 | From Associated Press
Jurors in the Vioxx trial heard testimony Monday from a pathologist who said the death of a man taking the drug was more than likely caused by a heart attack -- damaging Merck & Co.'s defense in the first Vioxx liability case to reach trial. The videotaped testimony from Dr.
BUSINESS
July 30, 2005 | From Associated Press
A New Jersey judge ruled that health plans that paid for members' Vioxx prescriptions can sue drug maker Merck & Co. as a class to recover billions of dollars they spent on the recalled painkiller. Superior Court Judge Carol E. Higbee in Atlantic City granted a motion filed by a labor union health plan to allow a nationwide class-action lawsuit to proceed under the state's consumer fraud act. Merck, based in Whitehouse Station, N.J., had opposed the motion.
BUSINESS
July 14, 2005 | From Associated Press
A jury of seven men and five women was seated Wednesday to decide the outcome of the nation's first Vioxx-related lawsuit to go to trial. The panel will begin hearing opening statements today in the courthouse in Angleton, about 40 miles south of Houston. The trial is expected to last five weeks. The Angleton case stems from the death in 2001 of Robert Ernst, a 59-year-old personal trainer and marathon runner.
BUSINESS
March 13, 2007 | From Bloomberg News
Merck & Co.'s Vioxx painkiller helped cause an Idaho mail carrier's heart attack, a New Jersey jury found, ordering the drug maker to pay him and his wife $47.5 million in a retrial of a case the man originally lost. Jurors in Atlantic City imposed actual damages of $20 million and punitive damages of $27.5 million after ruling that Vioxx was partly to blame for Frederick Humeston's 2001 heart attack.
BUSINESS
March 3, 2007 | From Reuters
Jurors in New Jersey found that Merck & Co. failed to provide adequate warnings about health risks tied to its withdrawn arthritis drug Vioxx in one case, but they decided that it gave adequate warning in another in two suits tried simultaneously.
BUSINESS
December 22, 2006 | From the Associated Press
A judge in a Texas widow's lawsuit over the Merck & Co. drug Vioxx on Thursday reduced a $32-million jury award to $8.7 million so that it conformed to state law. A state jury in April found Merck liable for the 2001 death of Leonel Garza, a 71-year-old man who had a fatal heart attack within a month of taking the since-withdrawn painkiller.
BUSINESS
December 16, 2006 | From Reuters
A Birmingham, Ala., jury handed Merck & Co. its second victory of the week in a Vioxx product liability trial, finding the drug maker did not hide the health risks associated with its withdrawn arthritis drug, or knowingly market a faulty product. Whitehouse Station, N.J.-based Merck had been sued by Gary Albright, 59, who blamed Vioxx for his 2001 heart attack.
BUSINESS
December 14, 2006 | From Bloomberg News
Merck & Co.'s Vioxx painkiller didn't cause a Tennessee man's 2003 heart attack, a federal jury ruled. Whitehouse Station, N.J.-based Merck withdrew Vioxx in 2004 after a study showed it doubled the risk of heart attacks. Anthony Wayne Dedrick, a 51-year-old smoker who, according to his lawyer, has diabetes, high cholesterol, a family history of heart disease and a history of cocaine use, suffered a heart attack after going on Vioxx.
BUSINESS
November 23, 2006 | From the Associated Press
Thousands of federal lawsuits claiming the drug Vioxx caused heart attacks and other conditions that killed or injured people cannot be pooled into one national class action, a judge ruled Wednesday. U.S. District Judge Eldon Fallon, who was appointed to deal with pretrial matters for all federal suits involving Merck & Co.'s withdrawn painkiller, did not rule on the possibility of separate personal injury class-action suits for each state and the District of Columbia.
BUSINESS
March 12, 2005 | From Bloomberg News
Merck & Co., which pulled its Vioxx painkiller from the market last year in the biggest drug recall, said it probably doesn't have enough insurance to cover the costs of lawsuits associated with the withdrawal. The company has $630 million in product liability insurance for Vioxx, after deductibles and co-insurance, Whitehouse Station, N.J.-based Merck said in a Securities and Exchange Commission filing.
BUSINESS
November 12, 2005 | From Associated Press
The next Vioxx product-liability case to come to trial in New Jersey probably will be a tougher battle for manufacturer Merck & Co., which last week got its first courtroom victory in a case involving short-term use of the now-withdrawn painkiller. New Jersey Superior Court Judge Carol E.
BUSINESS
November 16, 2006 | From the Associated Press
A federal jury cleared Merck & Co. in the July 2003 heart attack suffered by a Utah bank credit manager who had taken the once-popular painkiller Vioxx for 10 1/2 months. Charles Laron "Ron" Mason, 64, of Salt Lake County, Utah, began taking Vioxx after years of taking anti-inflammatory drugs because of back pain. Merck won two previous federal cases and lost the third. In state court, it has won three cases and lost three.
BUSINESS
October 4, 2006 | From Bloomberg News
Merck & Co. will face about 40,000 claims over its withdrawn Vioxx painkiller once deadlines for filing lawsuits lapse around the U.S., court records and lawyer estimates show. Most suits over the drug have been filed in state courts in New Jersey and California or are being managed by a federal judge in New Orleans. Merck faced about 30,000 claims in those courts just before a key Sept. 30 deadline, court officials said.
Los Angeles Times Articles
|